Biotech Sector in Focus Morningstar Highlights Potential Opportunities URGN Q1 2026 Earnings Narrower Loss Beats Estimates Shares Slip Despite Surprise CVS Expands Obesity Drug Coverage Adds Zepbound and Eli Lillys New Oral Pill